Owing to the protective effects of FGF21 on cholestasis-induced liver fibrosis, we further analyzed the beneficial effects of NaB, a well-known gut-microbiota-derived SCFA, to induce FGF21 expression in the liver through activation of PPARα (Kundu et al., 2019). The gene discussed is PPARA; the disease is cholestasis.